Cargando…
3D Bioprinting for Next-Generation Personalized Medicine
In the past decade, immense progress has been made in advancing personalized medicine to effectively address patient-specific disease complexities in order to develop individualized treatment strategies. In particular, the emergence of 3D bioprinting for in vitro models of tissue and organ engineeri...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094501/ https://www.ncbi.nlm.nih.gov/pubmed/37047328 http://dx.doi.org/10.3390/ijms24076357 |
_version_ | 1785023857123393536 |
---|---|
author | Lam, Ethan Hau Yin Yu, Fengqing Zhu, Sabrina Wang, Zongjie |
author_facet | Lam, Ethan Hau Yin Yu, Fengqing Zhu, Sabrina Wang, Zongjie |
author_sort | Lam, Ethan Hau Yin |
collection | PubMed |
description | In the past decade, immense progress has been made in advancing personalized medicine to effectively address patient-specific disease complexities in order to develop individualized treatment strategies. In particular, the emergence of 3D bioprinting for in vitro models of tissue and organ engineering presents novel opportunities to improve personalized medicine. However, the existing bioprinted constructs are not yet able to fulfill the ultimate goal: an anatomically realistic organ with mature biological functions. Current bioprinting approaches have technical challenges in terms of precise cell deposition, effective differentiation, proper vascularization, and innervation. This review introduces the principles and realizations of bioprinting with a strong focus on the predominant techniques, including extrusion printing and digital light processing (DLP). We further discussed the applications of bioprinted constructs, including the engraftment of stem cells as personalized implants for regenerative medicine and in vitro high-throughput drug development models for drug discovery. While no one-size-fits-all approach to bioprinting has emerged, the rapid progress and promising results of preliminary studies have demonstrated that bioprinting could serve as an empowering technology to resolve critical challenges in personalized medicine. |
format | Online Article Text |
id | pubmed-10094501 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100945012023-04-13 3D Bioprinting for Next-Generation Personalized Medicine Lam, Ethan Hau Yin Yu, Fengqing Zhu, Sabrina Wang, Zongjie Int J Mol Sci Review In the past decade, immense progress has been made in advancing personalized medicine to effectively address patient-specific disease complexities in order to develop individualized treatment strategies. In particular, the emergence of 3D bioprinting for in vitro models of tissue and organ engineering presents novel opportunities to improve personalized medicine. However, the existing bioprinted constructs are not yet able to fulfill the ultimate goal: an anatomically realistic organ with mature biological functions. Current bioprinting approaches have technical challenges in terms of precise cell deposition, effective differentiation, proper vascularization, and innervation. This review introduces the principles and realizations of bioprinting with a strong focus on the predominant techniques, including extrusion printing and digital light processing (DLP). We further discussed the applications of bioprinted constructs, including the engraftment of stem cells as personalized implants for regenerative medicine and in vitro high-throughput drug development models for drug discovery. While no one-size-fits-all approach to bioprinting has emerged, the rapid progress and promising results of preliminary studies have demonstrated that bioprinting could serve as an empowering technology to resolve critical challenges in personalized medicine. MDPI 2023-03-28 /pmc/articles/PMC10094501/ /pubmed/37047328 http://dx.doi.org/10.3390/ijms24076357 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Lam, Ethan Hau Yin Yu, Fengqing Zhu, Sabrina Wang, Zongjie 3D Bioprinting for Next-Generation Personalized Medicine |
title | 3D Bioprinting for Next-Generation Personalized Medicine |
title_full | 3D Bioprinting for Next-Generation Personalized Medicine |
title_fullStr | 3D Bioprinting for Next-Generation Personalized Medicine |
title_full_unstemmed | 3D Bioprinting for Next-Generation Personalized Medicine |
title_short | 3D Bioprinting for Next-Generation Personalized Medicine |
title_sort | 3d bioprinting for next-generation personalized medicine |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094501/ https://www.ncbi.nlm.nih.gov/pubmed/37047328 http://dx.doi.org/10.3390/ijms24076357 |
work_keys_str_mv | AT lamethanhauyin 3dbioprintingfornextgenerationpersonalizedmedicine AT yufengqing 3dbioprintingfornextgenerationpersonalizedmedicine AT zhusabrina 3dbioprintingfornextgenerationpersonalizedmedicine AT wangzongjie 3dbioprintingfornextgenerationpersonalizedmedicine |